Brendon M. Stiles, MD

home / authors / brendon-stiles-md

Articles

Sandip P. Patel, MD, professor, medicine, Department of Medicine, University of California, San Diego; Brendon M. Stiles, MD, professor, cardiothoracic surgery, chief, Divisions of Thoracic Surgery and Surgical Oncology, Department of Cardiothoracic & Vascular Surgery, associate director, Surgical Oncology, Montefiore Einstein Comprehensive Cancer Center

FDA Approval Insights: Perioperative Durvalumab for Resectable NSCLC

Sandip P. Patel, MD;Brendon M. Stiles, MD

October 3rd 2024

Drs Patel and Stiles discuss the significance of the FDA approval of perioperative durvalumab for patients with resectable non–small cell lung cancer.

Dr Stiles on the FDA Approval of Perioperative Durvalumab Plus Chemo in NSCLC

Brendon M. Stiles, MD

August 15th 2024

Brendon M. Stiles, MD, discusses the FDA approval of perioperative durvalumab plus chemotherapy in early-stage non–small cell lung cancer.

Montefiore Einstein Cancer Center hopes to begin combating systemic inequities and improve cancer outcomes for historically disadvantaged populations by taking a data-driven approach to delivering neoadjuvant therapy in communities that are economically and socially marginalized.

BRONx-CAN Program Aims to Deliver the Best Cancer Treatments Early

Brendon M. Stiles, MD;Vikas Mehta, MD, MPH, FACS

December 1st 2022

Montefiore Einstein Cancer Center hopes to begin combating systemic inequities and improve cancer outcomes for historically disadvantaged populations by taking a data-driven approach to delivering neoadjuvant therapy in communities that are economically and socially marginalized.

Brendon Stiles, MD, of New York-Presbyterian Hospital

Dr. Stiles on Treatment Advances Made in Early-Stage Lung Cancer

Brendon M. Stiles, MD

January 18th 2021

Brendon Stiles, MD, discusses the roles of surgery, radiation, and chemotherapy in treatment for early-stage lung cancer.

Multidisciplinary Management of Patients With Stage III NSCLC

Mark A. Socinski, MD, AdventHealth Cancer Institute;Roy S. Herbst, MD, PhD, Yale Cancer Center;Stephen Liu, MD, Georgetown Lombardi Comprehensive Cancer Center;Kristin Higgins, MD, City of Hope;Brendon M. Stiles, MD

July 13th 2020

Integrating Perioperative Immunotherapy Strategies in NSCLC

July 13th 2020

Molecular testing in Patients With Metastatic NSCLC

July 13th 2020

ADAURA: Osimertinib as Adjuvant Therapy in Stage III EGFR+ NSCLC

July 13th 2020

Varied Timing of IO Therapy in Patients With Stage III NSCLC

July 13th 2020

Treating for Stage III NSCLC After Progression on Durvalumab

July 13th 2020

Durvalumab in Stage III NSCLC Based on Performance Status

July 13th 2020

PACIFIC Trial: Durvalumab Following Chemotherapy for Stage III NSCLC

July 13th 2020

Mediastinal Staging in Non–Small Cell Lung Cancer

July 13th 2020

Dr. Stiles on Surgical Considerations in Lung Cancer

Brendon M. Stiles, MD

November 12th 2019

Brendon Stiles, MD, discusses considerations for surgery in lung cancer.

There's an App for That: Keeping Patients and Physicians on Track

Janey C. Peterson, MA, MS, RN, EdD;Brendon M. Stiles, MD;Heather Yeo, MD, MHS

September 1st 2016

In a pilot study, funded by both the Society for Surgery of the Alimentary Tract and The Center for Advanced Digestive Care, researchers at Weill Cornell Medicine are testing a new mobile app that could help transform postoperative patient monitoring.